Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

AQT90 FLEX Opens Up for a New and Better Way of Measuring Troponin T at the Point of Care

September 20, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

AQT90 FLEX Opens Up for a New and Better Way of Measuring Troponin... -- COPENHAGEN, September 20, 2010 /-

Cellectis bioresearch and Helix Biocon Join Forces for the Promotion of cGPS® and cGPS® Custom Kits and Cell Line Engineering Services in India

September 20, 2010 1:35 am | by Bio-Medicine.Org | News | Comments

PARIS and NEW DELHI, India, Sept. 20 /- Cellectis bioresearch, the specialist in genome customization and subsidiary of Cellectis (Alternext: ALCLS), and Helix BioService & Consultants Pvt Ltd (Helix Biocon), today announced that they will join forces for the promotion of Cellectis...

Biodel Appoints Arthur Urciuoli to its Board of Directors

September 17, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

DANBURY, Conn., Sept. 17 /- Biodel Inc. (Nasdaq: BIOD ) announced today the appointment of Arthur Urciuoli to the company's board of directors.  Mr. Urciuoli is chairman of ArcherGroup, a private investment and consulting services firm, and was recently elected to the board of the...

Advertisement

Pharmasset to Present at the UBS Global Life Sciences Conference

September 17, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Sept 17 /- Pharmasset, Inc. (Nasdaq: VRUS ) announces that management will present at the UBS Global Life Sciences Conference to be held September 20-22, 2010 at the Grand Hyatt, New York, NY. Schaefer Price, Pharmasset's President and Chief Executive Officer, will...

Henry Schein to Present at the UBS Global Life Sciences Conference

September 17, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

MELVILLE, N.Y., Sept. 17 /- Henry Schein, Inc., (Nasdaq: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that Steven Paladino, Henry Schein's Executive Vice President and Chief Financial Officer, will present at the UBS...

Cynosure to Present at UBS Global Life Sciences Conference

September 16, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

WESTFORD, Mass., Sept. 16 /- Cynosure, Inc. (Nasdaq: CYNO ), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it will present at the UBS Global Life Sciences Conference in New York on Tuesday, September 21. The...

Reportlinker Adds Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

September 16, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 16 /- Reportlinker.com announces that a new market research report is available in its catalogue: Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...

LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results

September 16, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla., Sept. 16 /- LightPath Technologies, Inc. (Nasdaq: LPTH ) (the "Company", "LightPath", or "we"), a global manufacturer, distributor and integrator of patented optical components and high-level assemblies, announced today its financial results for the fourth quarter and...

Advertisement

Olympus Launches 2011 National Innovation Awards Program

September 16, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

CENTER VALLEY, Pa., Sept. 16 /- Olympus, a precision technology leader designing and delivering innovative solutions in its core business areas of Medical and Surgical Products, Life Science Imaging Systems, Industrial Measurement and Imaging Instruments and Cameras and Audio Products,...

ISTA Pharmaceuticals Initiates Phase 3 Clinical Program for REMURA™ in Dry Eye Disease

September 16, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Sept. 16 /- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced that it has initiated a Phase 3 clinical program of ISTA's proprietary formulation of REMURA™ (bromfenac ophthalmic solution for dry eye) for alleviating the signs and symptoms of dry eye...

PDL BioPharma Announces Retirement of $54.3 Million of 2.75% Convertible Notes Due 2023

September 16, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

INCLINE VILLAGE, Nev., Sept. 16 /- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) announced today that it has completed the retirement of the remaining $54.3 million in aggregate principal of the Company's 2.75% Convertible Subordinated Notes, due August 16, 2023 (the "2023 Notes") in exchange...

Cornerstone OnDemand & #8217;s New Observation Checklist Offers Innovative Approach to Evaluating Real-Time Performance

September 16, 2010 5:32 am | by RealWire | News | Comments

Cornerstone among the only talent management solutions to help organisations observe and measure employee competencies and performance on the fly and in the field London, September 16, 2010 - The ability to manage performance in industries such as healthcare, manufacturing and education...

Canon Communications to be Sold to United Business Media; Transaction Expands Global Reach of Canon's Advanced Manufacturing and Design Focus

September 16, 2010 2:32 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Sept. 16 /- Canon Communications LLC today announced that it has agreed to be acquired by United Business Media Limited, a leading global business media company.  The agreement was arranged by Apprise Media, LLC , the management/investment company of Canon Chairman and...

Advertisement

National Survey of Physicians Reveals Common Misperceptions Concerning Misuse and Abuse of Opioids in Light of New Government Statistics

September 15, 2010 9:32 pm | by Bio-Medicine.Org | News | Comments

BALTIMORE, Sept. 16 /- Findings from a new national survey, sponsored by the American Pain Foundation, reveal misperceptions among physicians regarding the misuse and abuse of opioids. The results come in light of government statistics to be released today looking at the broader U.S....

Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee

September 15, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Sept. 15 /PRNewswire-USNewswire/ -- A home medical equipment provider testifies today about the negative impact of Medicare's controversial "competitive" bidding program for durable medical equipment and services. Karen A. Lerner, a registered nurse and wound care specialist...

HydroCision Announces New Investment to Accelerate Growth of Novel Fluidjet Technology for Minimally Invasive Spine Surgery

September 15, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

NORTH BILLERICA, Mass., Sept. 15 /- HydroCision Inc. ( www.hydrocision.com ), a privately held medical device company, announced today the purchase of the majority of the Company by new investors, led by venture capital firms Volcano Capital, Bioventures, and Omega Funds. HydroCision is...

Astellas Awards Scholarships to 12 Transplant Recipients and Donors Who Embody Hope, Courage and Achievement

September 15, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

DEERFIELD, Ill., Sept. 15 /- Astellas Pharma US, Inc. has announced the winners of the second 2010 Transplant Scholars Awards, which awarded a dozen $5,000 educational scholarships to transplant recipients and living donors from around the country to help them pursue their educational...

CareFusion and Blue Cross and Blue Shield of Illinois Create Illinois Hospital Quality Initiative to Help Eliminate Health Care-Associated Infections

September 15, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 15 /- CareFusion and Blue Cross and Blue Shield of Illinois today announced that 23 hospitals have formed the Illinois Hospital Quality Initiative (IHQI), a partnership created to improve clinical outcomes and cut health care costs by reducing health care-associated...

Isis Pharmaceuticals to Present at the UBS Global Life Sciences Conference

September 14, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Sept. 14 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at UBS' Global Life Sciences Conference on Tuesday, September 21, 2010 at 4:00 p.m. ET at the Grand Hyatt New...

Quinton Oswald Named Chief Executive Officer of SARcode Corporation

September 14, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

BRISBANE, Calif., Sept. 14 /- SARcode Corporation, a privately-held biotechnology company focused on developing a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists, today announced that Quinton Oswald has joined the company as Chief Executive Officer. Mr. Oswald...

TeleHealth Services and Reading Hospital and Medical Center Partner to Reach Technology-Driven Patient Education Goals

September 14, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

READING, Pa. and RALEIGH, N.C., Sept. 14 /- TeleHealth Services, the nation's leading provider of healthcare grade televisions and interactive patient education solutions, today announced a new partnership with The Reading Hospital and Medical Center (TRHMC). The 671-bed hospital chose...

Stereotaxis to Present at the CL King Best Ideas Conference and the Stifel Nicolaus Healthcare Conference

September 14, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Sept. 14 /- Stereotaxis, Inc. (Nasdaq: STXS ) today announced that executive management will present at the following investor conferences: The CL King 8th Annual Best Ideas Conference to be held September 15-16, 2010 at the Omni Berkshire Place Hotel in New York City....

ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firm's Growing Client Base in Germany

September 14, 2010 12:33 am | by Bio-Medicine.Org | News | Comments

FRANKFURT, Germany, Sept. 14 /- Dr. Rolf Badenhoop M.D., a 20-year veteran of the consulting and pharmaceutical industries in Europe, recently joined global sales and marketing consulting firm ZS Associates as associate principal. Badenhoop is based in the company's Frankfurt office. "I...

RSB Spine, LLC, Announces Additional FDA Clearance for the InterPlate® L-Ti

September 13, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Sept. 13 /- RSB Spine, LLC, today announced that the InterPlate® L-Ti has been cleared for an additional product code (KWQ).  The L-Ti was previously cleared as an interbody fusion device. RSB Spine Chief Executive Officer John A. Redmond said: "We are excited about...

MarketsandMarkets: Magnetic Resonance Imaging (MRI) Global Market Worth US$ 5,844.4 Million By 2015

September 13, 2010 6:31 am | by Bio-Medicine.Org | News | Comments

MarketsandMarkets: Magnetic Resonance Imaging (MRI) Global Market Worth US$ 5,844.4 Million By 2015 -- DALLAS, September 13, 2010 /-

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading